அட்லாண்டிக் சிகிச்சை News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Global Pelvic Floor Stimulators Market to exhibit CAGR of 8 8% by 2031 end | FMI

Global Pelvic Floor Stimulators Market to exhibit CAGR of 8 8% by 2031 end | FMI
pharmiweb.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from pharmiweb.com Daily Mail and Mail on Sunday newspapers.

Plot noMurmanskaya oblastUnited arab emiratesUnited statesSouth africaSouth koreaAbhishek budholiyaMedizintechnik gmbPrometheus groupUtah medical products incIncontrol medical ltdZynex incVerity medical ltdChiaro technology ltdLaborie incMedtronic plc

EPO - New case studies show routes to success

EPO - New case studies show routes to success
epo.org - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from epo.org Daily Mail and Mail on Sunday newspapers.

Caroline pampAndreas martsmanSweden chalmers university of technologyUniversity college dublinChalmers universityDermis pharmaBiomedical researchAtlantic therapeuticsஸ்வீடந் சால்மர்ஸ் பல்கலைக்கழகம் ஆஃப் தொழில்நுட்பம்பல்கலைக்கழகம் கல்லூரி டப்ளின்சால்மர்ஸ் பல்கலைக்கழகம்உயிர் மருத்துவ ஆராய்ச்சிஅட்லாண்டிக் சிகிச்சை

Sligo biotech start-up Nektr secures €1m in funding

Sligo biotech start-up Nektr secures €1m in funding Frank Boyle, CEO of Nektr Technologies. Image: WDC The start-up is developing a compound that could help in tackling antibiotic resistance in humans and animals. Nektr Technologies, a Sligo-based biotech start-up, has raised €1m in funding to bring its technology from trial stages to market. It is developing a synthetic antimicrobial compound that could make treatments like antibiotics more effective for humans and animals. Half of the funding round comes from the Western Development Commission (WDC), with other backers including Enterprise Ireland also investing. Nektr’s technology, called A3IS, is hoped to be able to combat against multi-drug resistant pathogens. The start-up is exploring the application of its compound in dermatological conditions, nasal decontamination and medical device coatings.

Gillian buckleyFrank boyleInvestment fundProtek medical to koch industriesDevelopment commissionWestern development commissionEnterprise irelandProtek medicalKoch industriesAtlantic therapeuticsகில்லியன் பக்லிவெளிப்படையான பாயில்முதலீடு நிதிவளர்ச்சி தரகுமேற்கு வளர்ச்சி தரகுநிறுவன ஐயர்ல்யாஂட்

Leading Femtech Brand INNOVO Attracts Two New Investors

Leading Femtech Brand INNOVO Attracts Two New Investors News provided by Share this article Share this article INNOVO adds significant incremental investment for pioneering home-based treatment for stress urinary incontinence, a condition that impacts 1 in 3 women worldwide Netherland s Borski Fund backs female-led, femtech focused companies Largest single investment Ireland s Western Development Commission has made to date Financing will support the expansion of Atlantic Therapeutics commercialization activities into their core US & UK markets & beyond GALWAY, Ireland, March 8, 2021 /PRNewswire/ Atlantic Therapeutics, the Galway-based company pioneering a non-invasive, wearable treatment for urinary incontinence, today announced it has raised significant new investment from the Borski Fund (Netherlands) and the Western Development Commission (Ireland).

United statesUnited kingdomSimone brummelhuisSusan trentGillian buckleyDanny fordeBorski fund netherlandsIreland western development commissionBorski fundDevelopment commissionNetherland borski fundDevelopment commission irelandInvestment fundSeroba life sciencesWestern development commissionAtlantic therapeutics

Western Development Commission to invest €2 million in Atlantic Therapeutics

Galway Bay FM 16 February 2021 Anthony Cheung, VP of Finance, Atlantic Therapeutics and Gillian Buckley, Investment Manager at WDC Largest single investmentÂ the Western Development CommissionÂ hasÂ madeÂ to date Financing will support the expansion of Atlantic Therapeutics commercialization activities from their Co. Galway base. Â Technology is used to treat urinary incontinenceÂ that impacts 1 in 3 womenÂ worldwideÂ Â Â Atlantic Therapeutics, the Galway-based company pioneering a non-invasive, wearable treatment for urinary incontinence, today announced it has raised Â2 millionÂ fromÂ The Western Development CommissionÂs investment fund.Â This is the largest single investmentÂ the WDCÂ Investment Fund haveÂ made to date and is complemented by returning investorsÂ SerobaÂ Life Sciences,Â Earlybird, LSP, Andera Partners andÂ AtlanticÂ Bridge, who continue their ongoing support for Atlantic Therapeutics with a substantial u

Galway bayUnited kingdomGillian buckleyAndrew downesAnthony cheungInvestment fundLife sciencesDevelopment commissionSeroba life sciencesAtlantic therapeuticsInvestment managerWestern development commissionAndera partnersAtlantic bridgeகால்வே வளைகுடாஒன்றுபட்டது கிஂக்டம்